ABSTRACT
INTRODUCTION
Cardiac hypertrophy is compensatory changes of cardiomyocytes caused by all kinds of mechanical stimulation, oxidative stress, neural endocrine hormone and cytokine stimulation. Cardiac hypertrophy is characterized by increased myocardial cell size and protein synthesis, recurrence of fetal genes, change of contraction force and so on. A certain degree of hypertrophy can be compensated, and maintain the normal function of the heart. But continued hypertrophy eventually results in decompensation and lead to change of the structure and function of the heart, and develop to heart failure in the end. Therefore actively control the development of cardiac hypertrophy is important to control the occurrence of heart failure development. It is reported that celecoxib can prevent cardiac hypertrophy and dysfunction by inhibiting apoptosis, inflammation and oxidative stress 1 . KMUP-1 attenuates endothelin-1-inducd cardiomyocyte hypertrophy through suppression of the Akt/GSK-3β pathway 2 . Resistin is a kind of adipokine. It has the effect of insulin resistance. Human resistin gene is located on the 19th chromosome and the molecular weight is 12.5 KDa. Many researchers found that resistin is associated with diseases such as obesity, diabetes and cardiovascular disease. In the myocardial tissue of patients with diabetes, resistin levels are increased significantly 3 . Resistin can destroy glucose metabolism in myocardial cells, which affects the structure and function of the heart 4 . Recombinant human resistin can aggravate myocardial ischemia-reperfusion injury and increase expression of ANP and BNP via NF-κB signaling pathway 5 .
Resistin is mainly expressed in infarction lesions in animal models of myocardial infarction 6 . Resistin can reduce human coronary artery endothelial nitric oxide synthase expression 7 , increase its permeability 8 and stimulate monocytes infiltration 9 . Excessive expression of resistin not only promotes myocardial tissue fibrosis, cell apoptosis and oxidative stress but also reduces the contraction force and changes structure of the heart 10 . Cathepsins belong to lysosomal proteases and play important roles in cardiovascular diseases 11 . Cathepsin K (Cat K) is one of the most important enzymes in the family of lysosomal proteases. Cathepsin K was found in inflammatory macrophages first, it is the key of bone resorption protease 12, 13 . The expression of cathepsin K is obviously higher in the myocardial tissue of patients with heart failure, dilated and hypertrophic cardiomyopathy 14, 15 . The expression of cathepsin K is closely related to the development of chronic heart failure, and cathepsin K can be used as a biomarker of cardiac remodeling and dysfunction 16 . ODN is a selective and reversible inhibitor of cathepsin K. A large number of clinical and experimental studies have found that ODN treatment for osteoporosis has obvious effects 17 . ODN can interfere with a variety of precursor and mature cathepsin K transport pathways. The aim of the this study was to evaluate the effects of ODN on resistin-induced cardiacmyocyte hypertrophy. 
MATERIALS AND METHODS

Reagents
H9c2 cell culture
H9c2 rat cardiomyoblast cells were cultured in DMEM containing 10% FBS, 1% penicillin and 1% penicillin/streptomycin at a temperature of 37˚C with a 5% CO2 atmosphere. Once cells had covered the area of culture bottle bottom 70% to 80%, they were passaged according to a 1:2 or 1:3 proportion. The medium was changed every 2 days. Cells were seeded into a 3.5 cm 2 culture dish at a density of 1x10 5 . Cells were cultured overnight, and then replaced the medium with serumfree medium for 24 h. Cells were treated with resistin at a concentration of 50 ng/ml 18 and ODN at a concentration of 300 nM 19 for the indicated time.
Determination of cell surface area 8x10 4 cells were seeded into 3.5 cm 2 dishes. Cells were cultured with serum-free DMEM for 24 h. Cells were treated with resistin for 48 h or treated with ODN for 2 h and then replaced it with resistin for 46 h. The cell surface area was measured with ImageJ software (NIH ImageJ version 1.49 software, Bethesda, MD, USA). Five observation fields were selected at random and 10 cells in each observation field were selected for measurement of cell surface area 18 .
Protein synthesis measurement 1x10
5 cells were seeded into 3.5 cm 2 dishes. After cells were cultured with serumfree DMEM for 24 h, cells were treated with resistin for 48 h or treated with ODN for 2 h and then replaced it with resistin for 46 h. The cells were collected and lysed in 70 µl of total protein lysis buffer. Protein concentrations were detected by BCA protein quantitative kit (Boster, Wuhan, China). Cell protein synthesis was determined by dividing the total amount of protein by the cell number 18 .
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
RNA was extracted using the UNIQ-10 column TRIzol kit (Shanghai Sangon Biotech, Shanghai, China) and treated with DNase. A total of 1 µg of RNA was reverse transcribed to cDNA using the PrimeScript®RT Master Mix Perfect RealTime Kit (Takara). According to the manufacturer's instructions, PCR amplification was conducted with SYBR® Premix Ex Taq™ II kit (Takara) using the Applied Biosystems® 7500 Fast Real-Time PCR System (Thermo Fisher Scientific Inc., Waltham, MA, USA). The PCR reaction condition was: 95˚C for 10 min, 95℃ for 15 sec, and then 40 cycles of 60˚C for 1 min. GAPDH was used as a reference gene. The Cq method was used for relative quantification. The BNP, β-MHC and GAPDH primers were designed and synthesized by Shanghai Sangon Biotech Co., Ltd. The nucleotide sequences of the primers were as follows: BNP forward, 5′-TCTGGGACCACCTCTCAAGT-3′  and  reverse,  5′-GGCAAGTTTGTGCTGGAAGA-3′;  β-MHC  forward,  5′-CAGAACACCAGCCTCATCAA-3′  and  reverse,  5′-CCTCTGCGTTCCTACACTCC-3′;  GAPDH  forward,  5′-ATCACCATCTTCCAGGAGCGA-3′ and reverse, 5′-AGCCTTCTCCATGGTGGTGAA-3′.
Western blot analysis
Cells were collected and lysed to prepare protein. The protein concentration was measured with BCA kit (Beyotime Biotechnology, Beijing, China). 5X SDS-PAGE protein loading buffer (Boster, Wuhan, China) was added to samples, which were heated at 100˚C for 5 min. The proteins were separated by 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis. The proteins were transferred onto polyvinylidene fluoride membranes (EMD Millipore, Billerica, MA, USA). The membranes were blocked with TBST buffer (20 mM Tris-HCl, 150 mM NaCl and 0.1% Tween-20) containing 5% non-fat milk for 1 h at room temperature. The membranes were incubated in TBST buffer containing 5% non-fat milk with the primary antibodies p-LKB1 (cat. no. 3482S; monoclonal rabbit anti-rat; 1:1,000; Cell Signaling Technology, Inc.), LKB1 (cat. no. 3047S; monoclonal rabbit anti-rat; 1:1,000; Cell Signaling Technology, Inc.), p-AMPK (cat. no. 2531S; polyclonal rabbit anti-rat; 1:1,000; Cell Signaling Technology, Inc.), AMPK (cat. no. 5831S; monoclonal rabbit anti-rat; 1:1,000; Cell Signaling Technology, Inc.), β-actin (cat. no. 4967S; polyclonal rabbit anti-rat; 1:1,000; Cell Signaling Technology, Inc.) at 4˚C overnight. After primary antibodies incubation, the membranes were incubated with anti-rabbit secondary antibodies (cat. no. 111-035-003; polyclonal goat-anti rabbit; 1:10,000; Jackson ImmunoResearch, Inc., West Grove, PA, USA) conjugated to horseradish peroxidase at room temperature for 1 h. The protein bands were visualised using an chemiluminescence kit (Boster, Wuhan, China) and FluorChem™Q Quantitative Western Blot Imaging System (Bio-Techne, Minneapolis, MN, USA). The ratio of phosphorylated/unphosphorylated protein was measured with ImageJ software.
Statistical analysis SPSS 17.0 statistical software was used for data analysis. All experiments data were expressed as means ± SD. The comparison between multiple groups which satisfied with the normality and homogeneity of variance, the single factor analysis of variance was used, and pairwise comparison with LSD-t method. p < 0.05 is statistically different.
RESULTS
ODN treatment decreases H9c2 cell surface area which is increased by resistin
H9c2 cells were treated with resistin at 50 ng/ml for 48 h. Resistin increased cell surface area significantly compared to the control group (p < 0.01, Fig. 1 ). H9c2 cells were pretreated with ODN at 300 nM for 2 h and then treated with resistin. ODN significantly decreased cell surface area compared to the resistin group (p < 0.01, Fig. 1 ). 
ODN opposes the effect of resistin that increases cardiomyocyte protein synthesis
To investigate whether ODN treatment decreases resistin-induced protein synthesis in H9c2 cells, H9c2 cells were treated with resistin at 50 ng/ml for 48 h. Resistin increased protein synthesis significantly compared to the control group (p < 0.01, Fig. 2 ). H9c2 cells were pretreated with ODN at 300 nM for 2 h and then treated with resistin. ODN significantly decreased protein synthesis that was increased by resistin (p < 0.01, Fig. 2) . Fig. 3A, B) . 
ODN treatment increases the phosphorylation of LKB1 and AMPK decreased by resistin
To further investigate the underlying molecular mechanism by which OND inhibits resistin-induced cardiomyocyte hypertrophy, we evaluated the phosphorylation status of LKB1 and AMPK following resistin and ODN treatment by western blot. Treatment of resistin decreased phosphorylation of LKB1 and AMPK, whereas total LKB1 and AMPK protein expression was unchanged. Treatment of ODN increased expression of phosphorylated LKB1 and AMPK that was decreased by resistin (Fig.  4) . 
DISCUSSION
Many cardiovascular diseases such as coronary heart disease, hypertension, heart valve disease, are accompanied by varying degrees of cardiac hypertrophy. Finally, they develop into a heart failure. This is a serious threat to the lives of patients. Therefore, it is great significant to study the mechanism of cardiac hypertrophy for the diagnosis, treatment and prognosis of cardiac hypertrophy and heart failure. Resistin is a kind of adipokine. In recent years, more and more researches about resistin and cardiac hypertrophy have been studied. Excessive expression of resistin is associated with cardiac remodeling and dysfunction in rat 10 . Serum resistin levels are higher significantly in patients with hypertrophic cardiomyopathy 20 . Resistin overexpression can lead to the increase of the volume of myocardial cells, protein synthesis, the expression of hypertrophy marker ANP, BNP and β-MHC, which are through AMPK/mTOR and JNK/IRS1 signaling pathways 21 . Resistin can also induce myocardial hypertrophy through activating IRS1/MAPK signaling pathway 22 . In our present study, resistin treatment could increase cell surface area, protein synthesis, expression of BNP and β-MHC, which were consistent with the results of previous studies. LKB1 is a serine/threonine protein kinase that is expressed in almost all human tissues. LKB1 is a tumor suppressor gene closely related to the occurrence of many kinds of tumors 23 . The activation of LKB1 requires the binding of MO25 and STRAD to the complex 24 . The main function of LKB1 is to inhibit cell proliferation and promote cell apoptosis by inhibiting cell cycle in the G1 phase. LKB1 can phosphorylate downstream AMPK at threonine 172 to activate AMPK. LKB1 is discovered to be the key upstream activator of the AMPK 25 . AMPK is a serine/threonine protein kinase, which is widely existed in eukaryotes. It is formed by the three subunit of α, β and γ 26 . The activation of AMPK is mainly regulated by the intracellular AMP/ATP ratio, which is an intracellular energy regulator 27 . Any factors that lead to the increase of AMP/ATP ratio, such as metabolism, oxidative stress, ischemia and hypoxia, can activate the phosphorylation of AMPK. Many studies show that AMPK is closely related to cardiac hypertrophy. The activity of AMPK is significantly decreased in hypertrophic cardiac myocytes, and AMPK can limit the protein synthesis and the remodeling of the cytoskeleton, which can inhibit cardiac hypertrophy 28 . EGCG prevents phenylephrine-induced myocardial hypertrophy through activating AMPK signaling pathway 29 .
MicroRNA-451 promotes high fat diet induced myocardial hypertrophy by inhibiting the LKB1/AMPK signaling pathway 30 . Cathepsin K is a lysosomal protease involved in various biological activities. The expression of cathepsin K in myocardium of rats with heart failure is significantly higher than that in normal rats. Cathepsin K deficiency can effectively relieve pressure overload cardiac hypertrophy 31 . Cathepsin K induces cardiac hypertrophy by activating the mTOR signaling pathway. Cathepsin K gene knockout can inhibit the hypertrophy and apoptosis of cardiomyocytes, but does not change the myocardial fibrosis 32 . ODN is an inhibitor of cathepsin K. Through the experiments using ODN to intervene resistin-induced cardiomyocyte hypertrophy, we found that cell surface area, protein synthesis, BNP and β-MHC expression were significantly decreased, while LKB1 and AMPK phosphorylation levels were significantly increased after treatment with ODN and resistin.
CONCLUSION
Resistin can increase cardiomycyte size, protein synthesis and hypertrophic marker BNP and β-MHC mRNA expression. Resistin also decreases the activation of LKB1/AMPK pathway. Whereas ODN reverses these effects of resistin, suggesting ODN can inhibit resistin-induced H9c2 cell hypertrophy through the activation of LKB1/AMPK signaling pathway.
